The Carlo Alberto Canal connects Bormida and Tanaro rivers in Piedmont (ITALY). It was created for irrigation purposes but since its waters are suspected to be polluted, a sampling campaign was performed by the ARPA of Alessandria. The physico-chemical parameters analysed along 3 years (1998-2000) were investigated by multivariate chemometric methods. PCA showed that the waters situation depends heavily on the sampling period. Also a Kohonen self-organising map confirmed the clustering observed, providing insights into the causes of the clusterisation. New samplings are now being performed and a larger set of environmental variables is determined on each sample.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Correction: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey.
Updates Surg
October 2024
Division of Pancreatic Surgery and Transplantation, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey.
Updates Surg
June 2024
Division of Pancreatic Surgery and Transplantation, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
Article Synopsis
- A survey was conducted with surgeons to explore their use of intraperitoneal prophylactic drains (IPDs) during pancreaticoduodenectomy (PD), revealing varying practices and significant levels of regret associated with the decision to use or omit drains.
- The results showed that most surgeons (97.2%) used IPDs, with a high median regret score (84) for omitting the drain but much lower for using it (10).
- The study suggested that for low-risk patients, omitting IPDs could be a viable option, and the acceptance of this practice varies based on factors like surgical technique and perceptions of risk assessment.
The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic.
Front Med (Lausanne)
September 2023
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
Specific immune suppression types have been associated with a greater risk of severe COVID-19 disease and death. We analyzed data from patients >17 years that were hospitalized for COVID-19 at the "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" in Milan (Lombardy, Northern Italy). The study included 1727 SARS-CoV-2-positive patients (1,131 males, median age of 65 years) hospitalized between February 2020 and November 2022.
View Article and Find Full Text PDFBiomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trial.
BMJ Open
March 2023
Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Munster, North Rhine-Westphalia, Germany
Introduction: Previous studies demonstrated that the implementation of the Kidney Disease Improving Global Outcomes (KDIGO) guideline-based bundle, consisting of different supportive measures in patients at high risk for acute kidney injury (AKI), might reduce rate and severity of AKI after surgery. However, the effects of the care bundle in broader population of patients undergoing surgery require confirmation.
Methods And Analysis: The BigpAK-2 trial is an international, randomised, controlled, multicentre trial.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Am J Kidney Dis
July 2023
The George Institute for Global Health, University of New South Wales, New South Wales, Australia; Department of Nephrology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
Article Synopsis
- The CREDENCE study analyzed the effects of canagliflozin on adverse kidney and cardiovascular events in individuals with diabetic kidney disease, focusing on variations by age and sex.
- The study included a diverse participant group and assessed outcomes such as kidney failure, serum creatinine doubling, and cardiovascular-related death across different age groups (<60, 60-69, ≥70) and sexes.
- Results showed that canagliflozin significantly reduced the risk of adverse kidney events across all age groups and sexes without notable differences in safety outcomes or effectiveness based on these demographics.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!